Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Dr. Phillip Frost Ph.D.

Market Cap

871.24 Million USD

Sector

Healthcare

Website

https://www.opko.com

Last Update

2/22/2024, 12:00:00 PM

Description

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

Read More

Overview

Value

0

Growth

20

Health

28

Management

0

Analyst Opinion

63

Total

34

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Has a low level of debt
  • Low preportion of income is paid as dividend

Risk Factors

  • Overvalued on cashflow basis
  • Income is not covering expenditure and investment
  • Earnings are negative
  • Altman-Z score suggests a risk of bankruptcy
  • Poor overall financial health
  • Disliked by Twitter users
  • Poor earnings and cashflow growth
  • Dividend could be at risk

Market Peers

OPK

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

N/A

Revenue Growth (5 Year Average)

N/A

Ratings Consensus

Neutral

Share Buybacks

N/A

Dividend Yeild (TTM)

0.00%

Valuation

Value Score

0

  • Estimated intrinsic-value of N/A is lower than current price ( 1.25 USD)
  • Free-cashflow-yeild of -6.94% is worse than the market average (4.7%)
  • Margin-of-safety of N/A is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 2.1 USD

Current Price: 0.9 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-6.94%

PE/Earnings Growth

N/A

Price/Book

0.46x

Growth

Growth Score

20

  • Earnings growth has improved this year
  • Free Cashflow growth has improved this year
  • 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
  • Revenue growth has slowed this year
  • 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
  • 5 Year Average Free Cashflow growth of N/A is lower than the market average (12.35%)

Revenue Growth

N/A

Earnings Growth

N/A

Cashflow Growth

N/A

Health

Health Score

28

  • Has a low level of debt
  • Assets cover liabilities
  • Normal operation does not require debt to be sustainable
  • Cashflow is negative
  • Altman-Z score suggests a risk of bankruptcy
  • Debt repayments significantly impact cashflow

Altman Z Score

0.00

Piostroski Score

1.00

Debt/Equity

0.15x

Current Assets/Liabilities

2.49x

Free Cashflow/Total Debt

0.02x

Debt/Capital

0.31x

Dividend

Secure Dividend Score

0

  • Long term dividend payout ratio of 0.00% is considered good
  • Payout ratio (TTM) of 0.00% is lower than the average (40%)
  • Dividends have shown growth over the last 5 years
  • Spending a lower percentage of their income on dividends than last 5 years
  • Dividend yeild of 0.00% is less than the market average (1.85%)
  • Very unsafe

Dividend Yeild

0.00%

Dividend Growth

N/A

Payout Ratio (Earnings)

0.00%

Payout Ratio (Cashflow)

0.00%

Management

Management Score

0

  • Return-on-capital-employed of 5.92% is lower than the market average (10%)
  • Return-on-equity of -2.07% is lower than the market average (15%)

Average Buybacks/Dilution

N/A

Recent Buybacks/Dilution

7.55%

5 Year Price Volitility

12.76%

Return On Assets

-1.45%

Return On Capital Employed

5.92%

Return On Equity

-2.07%

Return On Free Cashflow

N/A

Return On Investments

N/A

Social Sentiment

Social Sentiment Score

26

Twitter Sentiment

0.00

Stocktwits Sentiment

51.00

Analysts

Analyst Opinion

63

  • Ratings consensus is Neutral

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

OPKO Health, Inc.

Currency

USD

Beta

1.792349

Vol Avg

3643970

Ceo

Dr. Phillip Frost Ph.D.

Cik

0000944809

Cusip

68375N103

Exchange

NASDAQ Global Select

Full Time Employees

4196

Industry

Diagnostics & Research

Sector

Healthcare

Ipo Date

1995-11-02

Address

4400 Biscayne Boulevard

City

Miami

State

FL

Country

US

Zip

33137

Phone

305 575 4100

Analysis Last Updated

2/22/2024, 12:00:00 PM

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies